• Home
  • About
  • Investors
  • Science
  • Announcements
cardiogeni.com

Cardiogeni PLC – Admission on AQSE and First Day of Dealings

by ollie@ojtdigital.com | Jan 31, 2025 | Uncategorized

Cardiogeni PLC – Admission on AQSE and First Day of Dealings RNS Number : 3634V Cardiogeni PLC 31 January 2025 31 January...
Next Entries »
Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

  • Home
  • About
  • Investors
  • Science
  • Announcements

Socials

  • Follow

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: